Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18626 | 543 | 39.0 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
419 | 2 | STATINS//EZETIMIBE//SIMVASTATIN | 16502 |
18626 | 1 | PITAVASTATIN//NK 104//CAS 147526 32 7 | 543 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PITAVASTATIN | authKW | 1831823 | 14% | 42% | 77 |
2 | NK 104 | authKW | 678816 | 2% | 93% | 13 |
3 | CAS 147526 32 7 | authKW | 455489 | 2% | 90% | 9 |
4 | TOKYO NEW DRUG S 1 | address | 239922 | 1% | 53% | 8 |
5 | STATINS | authKW | 219050 | 31% | 2% | 169 |
6 | PITAVASTATIN CALCIUM | authKW | 184031 | 1% | 55% | 6 |
7 | MONOCALCIUM BIS3R 5S 6E 7 2 CYCLOPROPYL 4 4 FLUOROPHENYL 3 QUINOLYL 3 5 DIHYDROXY 6 HEPTENOATE | authKW | 168700 | 1% | 100% | 3 |
8 | ARTERIOSCLEROT METAB MED | address | 112467 | 0% | 100% | 2 |
9 | HIGH INTENSITY STATINS | authKW | 112467 | 0% | 100% | 2 |
10 | IR DEPENDENT IRS 1 PI3K AKT PATHWAY | authKW | 112467 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 1721 | 23% | 0% | 124 |
2 | Endocrinology & Metabolism | 1647 | 22% | 0% | 119 |
3 | Peripheral Vascular Diseases | 1275 | 15% | 0% | 80 |
4 | Pharmacology & Pharmacy | 792 | 24% | 0% | 130 |
5 | Medicine, General & Internal | 243 | 11% | 0% | 61 |
6 | Medicine, Research & Experimental | 74 | 6% | 0% | 30 |
7 | Chemistry, Medicinal | 34 | 3% | 0% | 17 |
8 | Toxicology | 9 | 2% | 0% | 11 |
9 | Nutrition & Dietetics | 8 | 2% | 0% | 9 |
10 | Chemistry, Analytical | 5 | 3% | 0% | 16 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TOKYO NEW DRUG S 1 | 239922 | 1% | 53% | 8 |
2 | ARTERIOSCLEROT METAB MED | 112467 | 0% | 100% | 2 |
3 | NUCLEO INVEST ARTERIAL | 74977 | 0% | 67% | 2 |
4 | SHIRAOKA STN BIOL SCI | 67470 | 1% | 20% | 6 |
5 | BUCKINGHAM COURT | 56233 | 0% | 100% | 1 |
6 | CARDIOLUNION HOSPMINIST EDUC | 56233 | 0% | 100% | 1 |
7 | CARDIOVASC MED FALK CVRC | 56233 | 0% | 100% | 1 |
8 | CHOLESTEROL TREATMENT TRIALISTS ABORAT | 56233 | 0% | 100% | 1 |
9 | CLIN BIOL 2 | 56233 | 0% | 100% | 1 |
10 | DIABET CLIN SCI MALMOSUS MALMO | 56233 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ATHEROSCLEROSIS SUPPLEMENTS | 16426 | 2% | 3% | 9 |
2 | JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 11318 | 3% | 1% | 15 |
3 | CLINICAL LIPIDOLOGY | 7199 | 1% | 2% | 7 |
4 | ATHEROSCLEROSIS | 4428 | 5% | 0% | 29 |
5 | JOURNAL OF DIABETES INVESTIGATION | 1568 | 1% | 1% | 4 |
6 | CURRENT OPINION IN LIPIDOLOGY | 1517 | 1% | 0% | 6 |
7 | CURRENT ATHEROSCLEROSIS REPORTS | 1353 | 1% | 1% | 4 |
8 | ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 1300 | 1% | 0% | 7 |
9 | AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 1196 | 1% | 1% | 3 |
10 | CARDIOVASCULAR DIABETOLOGY | 1128 | 1% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CEDERBERG, H , STANCAKOVA, A , YALURI, N , MODI, S , KUUSISTO, J , LAAKSO, M , (2015) INCREASED RISK OF DIABETES WITH STATIN TREATMENT IS ASSOCIATED WITH IMPAIRED INSULIN SENSITIVITY AND INSULIN SECRETION: A 6 YEAR FOLLOW-UP STUDY OF THE METSIM COHORT.DIABETOLOGIA. VOL. 58. ISSUE 5. P. 1109 -1117 | 22 | 85% | 53 |
2 | BETTERIDGE, DJ , CARMENA, R , (2016) THE DIABETOGENIC ACTION OF STATINS - MECHANISMS AND CLINICAL IMPLICATIONS.NATURE REVIEWS ENDOCRINOLOGY. VOL. 12. ISSUE 2. P. 99 -110 | 40 | 49% | 5 |
3 | KOSTAPANOS, MS , LIAMIS, GL , MILIONIS, HJ , ELISAF, MS , (2010) DO STATINS BENEFICIALLY OR ADVERSELY AFFECT GLUCOSE HOMEOSTASIS?.CURRENT VASCULAR PHARMACOLOGY. VOL. 8. ISSUE 5. P. 612-631 | 61 | 46% | 32 |
4 | ARNABOLDI, L , CORSINI, A , (2015) COULD CHANGES IN ADIPONECTIN DRIVE THE EFFECT OF STATINS ON THE RISK OF NEW-ONSET DIABETES? THE CASE OF PITAVASTATIN.ATHEROSCLEROSIS SUPPLEMENTS. VOL. 16. ISSUE . P. 1 -27 | 78 | 27% | 8 |
5 | AGOURIDIS, AP , KOSTAPANOS, MS , ELISAF, MS , (2015) STATINS AND THEIR INCREASED RISK OF INDUCING DIABETES.EXPERT OPINION ON DRUG SAFETY. VOL. 14. ISSUE 12. P. 1835 -1844 | 40 | 55% | 3 |
6 | FILIPPATOS, TD , ELISAF, MS , (2016) PITAVASTATIN AND CARBOHYDRATE METABOLISM: WHAT IS THE EVIDENCE?.EXPERT REVIEW OF CLINICAL PHARMACOLOGY. VOL. 9. ISSUE 7. P. 955 -960 | 31 | 67% | 0 |
7 | BARYLSKI, M , NIKOLIC, D , BANACH, M , TOTH, PP , MONTALTO, G , RIZZO, M , (2014) STATINS AND NEW-ONSET DIABETES.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 22. P. 3657 -3664 | 34 | 60% | 5 |
8 | ROBINSON, JG , (2015) STATINS AND DIABETES RISK: HOW REAL IS IT AND WHAT ARE THE MECHANISMS?.CURRENT OPINION IN LIPIDOLOGY. VOL. 26. ISSUE 3. P. 228 -235 | 23 | 77% | 6 |
9 | MUSCOGIURI, G , SARNO, G , GASTALDELLI, A , SAVASTANO, S , ASCIONE, A , COLAO, A , ORIO, F , (2014) THE GOOD AND BAD EFFECTS OF STATINS ON INSULIN SENSITIVITY AND SECRETION.ENDOCRINE RESEARCH. VOL. 39. ISSUE 4. P. 137 -143 | 31 | 62% | 3 |
10 | KOH, KK , SAKUMA, I , QUON, MJ , (2011) DIFFERENTIAL METABOLIC EFFECTS OF DISTINCT STATINS.ATHEROSCLEROSIS. VOL. 215. ISSUE 1. P. 1 -8 | 35 | 49% | 58 |
Classes with closest relation at Level 1 |